霍普股份(301024.SZ):參與設立的產業投資基金減資
格隆匯4月17日丨霍普股份(301024.SZ)公佈,根據《麗水簡樸勤智股權投資合夥企業(有限合夥)之合夥協議》相關約定,簡樸勤智於2024年4月16日召開合夥人會議,全體合夥人決定縮減產業基金規模並進入退出期,簡樸勤智認繳出資總額由人民幣12,000萬元減少至3,700萬元,全體合夥人按實繳比例同比減少出資,其中公司認繳出資額由5,000萬元調整為947.5034萬元。公司前期已對產業基金實繳出資人民幣2,000萬元,根據本次減資安排,產業基金在扣除公司應承擔的合夥企業費用、託管費用、基金管理費和印花税等相關費用及預留存續期各項費用後,將退還公司出資差額人民幣973.5368萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.